Metastatic medulloblastoma in childhood: Chang's classification revisited

International Journal of Surgical Oncology

Volumn 2012, Issue , 2012, Pages

  Dufour, Christelle ^a   Beaugrand, Annick ^a   Pizer, Barry ^b   Micheli, Julie ^c   Aubelle, Marie Stephanie ^a   Fourcade, Aurelie ^a   Couanet, Dominique ^a   Laplanche, Agnes ^a   Kalifa, Chantal ^a   Grill, Jacques ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864842703     PISSN: 20901402     EISSN: 20901410     Source Type: Journal    
DOI: 10.1155/2012/245385     Document Type: Article

References (25)

1. Taylor R. E., Bailey C. C., Robinson K. J., Weston C. L., Walker D. A., Ellison D., Ironside J., Pizer B. L., Lashford L. S., Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. European Journal of Cancer 2005 41 5 727 734 2-s2.0-14844331808 10.1016/j.ejca.2004.12.017 (Pubitemid 40342556)
2. Chang C. H., Housepian E. M., Herbert C. Jr., An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969 93 6 1351 1359 2-s2.0-0014619880
3. Verlooy J., Mosseri V., Bracard S., Tubiana A. L., Kalifa C., Pichon F., Frappaz D., Chastagner P., Pagnier A., Bertozzi A. I., Gentet J. C., Sariban E., Rialland X., Edan C., Bours D., Zerah M., Le Gales C., Alapetite C., Doz F., Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study. European Journal of Cancer 2006 42 17 3004 3014 2-s2.0-33750533775 10.1016/j.ejca.2006.02.026 (Pubitemid 44667471)
4. Evans A. E., Jenkin R. D. T., Sposto R., Ortega J. A., Wilson C. B., Wara W., Ertel I. J., Kramer S., Chang C. H., Leikin S. L., Hammond G. D., The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. Journal of Neurosurgery 1990 72 4 572 582 2-s2.0-0025327476 (Pubitemid 20113683)
5. Merchant T. E., Wang M. H., Haida T., Lindsley K. L., Finlay J., Dunkel I. J., Rosenblum M. K., Leibel S. A., Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era. International Journal of Radiation Oncology Biology Physics 1996 36 1 29 35 2-s2.0-0029811115 10.1016/S0360-3016(96)00274-X (Pubitemid 26314149)
6. Miralbell R., Raymond.Miralbell@hcuge.ch Bieri S., Huguenin P., Feldges A., Morin A. M., Garcia E., Wagner H. P., Wacker P., Von Der Weid N., Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma. Annals of Oncology 1999 10 2 239 241 10.1023/A:1008363422189 (Pubitemid 29113187)
7. Sanders R. P., Onar A., Boyett J. M., Broniscer A., Morris E. B., Qaddoumi I., Armstrong G. T., Boop F. A., Sanford R. A., Kun L. E., Merchant T. E., Gajjar A., M1 Medulloblastoma: high risk at any age. Journal of Neuro-Oncology 2008 90 3 351 355 2-s2.0-56249092412 10.1007/s11060-008-9671-9
8. Zeltzer P. M., Boyett J. M., Finlay J. L., Albright A. L., Rorke L. B., Milstein J. M., Allen J. C., Stevens K. R., Stanley P., Li H., Wisoff J. H., Geyer J. R., McGuire-Cullen P., Stehbens J. A., Shurin S. B., Packer R. J., Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. Journal of Clinical Oncology 1999 17 3 832 845 2-s2.0-0033050817 (Pubitemid 29109313)
9. Meyers S. P., Wildenhain S. L., Chang J. K., Bourekas E. C., Beattie P. F., Korones D. N., Davis D., Pollack I. F., Zimmerman R. A., Postoperative evaluation for disseminated medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes. American Journal of Neuroradiology 2000 21 9 1757 1765 2-s2.0-0033776946
10. Gentet J. C., Doz F., Bouffet E., Plantaz D., Roche H., Tron P., Kalifa C., Mazingue F., Sariban E., Chastagner P., Bernard J. L., Brunat-Mentigny M., Raybaud C., Zucker J. M., Carboplatin and VP 16 in medulloblastoma: a phase II study of the French society of pediatric oncology (SFOP). Medical and Pediatric Oncology 1994 23 5 422 427 2-s2.0-0027932778 (Pubitemid 24296699)
11. Bouffet E., Gentet J. C., Doz F., Tron P., Roche H., Plantaz D., Thyss A., Stephan J. L., Lasset C., Carrie C., Alapetite C., Choux M., Mottolese C., Visot A., Zucker J. M., Brunat-Mentigny M., Bernard J. L., Metastatic medulloblastoma: the experience of the French cooperative M7 group. European Journal of Cancer Part A 1994 30 10 1478 1483 2-s2.0-0028034121 10.1016/0959-8049(94)00256-5 (Pubitemid 24343009)
12. Dufour C., Sequential high-dose chemotherapy with autologous stem cell rescue for children with high-risk medulloblastoma and supratentorial primitive neuroectodermal tumours. Neuro-Oncology 2008 10 3 488
13. Vassal G., Tranchand B., Valteau-Couanet D., Mahé C., Couanet D., Schoeppfer C., Grill J., Kalifa C., Hill C., Ardiet C., Hartmann O., Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma. Bone Marrow Transplantation 2001 27 5 471 477 2-s2.0-17744398815 10.1038/sj.bmt.1702806 (Pubitemid 32266496)
14. Dufour C., Sequential high-dose chemotherapy and reduced craniospinal irradiation in young children with metastatic medulloblastoma. Neuro-Oncology 2008 10 3 423
15. Kaplan E., Meier P., Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958 53 457 481
16. Rothman K. J., Estimation of confidence limits for the cumulative probability of survival in life table analysis. Journal of Chronic Diseases 1978 31 8 557 560 2-s2.0-0018094626 (Pubitemid 9027411)
17. Schemper M., Smith T. L., A note on quantifying follow-up in studies of failure time. Controlled Clinical Trials 1996 17 4 343 346 2-s2.0-0029851283 10.1016/0197-2456(96)00075-X (Pubitemid 26342716)
18. Cox D., Regression models and life-tables. Journal of the Royal Statistical Society. Series B 1972 34 2 187 220
19. Albright A. L., Wisoff J. H., Zeltzer P. M., Boyett J. M., Rorke L. B., Stanley P., Effects of medulloblastoma resections on outcome in children: a report from the children's cancer group. Neurosurgery 1996 38 2 265 271 2-s2.0-0030054211 10.1097/00006123-199602000-00007 (Pubitemid 26030705)
20. Packer R. J., Sutton L. N., Elterman R., Lange B., Goldwein J., Nicholson H. S., Mulne L., Boyett J., D'Angio G., Wechsler-Jentzsch K., Reaman G., Cohen B. H., Bruce D. A., Rorke L. B., Molloy P., Ryan J., LaFond D., Evans A. E., Schut L., Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. Journal of Neurosurgery 1994 81 5 690 698 2-s2.0-0028080028 (Pubitemid 24328694)
21. Bailey C. C., Gnekow A., Wellek S., Jones M., Round C., Brown J., Phillips A., Neidhardt M. K., Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Medical and Pediatric Oncology 1995 25 3 166 178 2-s2.0-0029119268 10.1002/mpo.2950250303
22. Gajjar A., Chintagumpala M., Ashley D., Kellie S., Kun L. E., Merchant T. E., Woo S., Wheeler G., Ahern V., Krasin M. J., Fouladi M., Broniscer A., Krance R., Hale G. A., Stewart C. F., Dauser R., Sanford R. A., Fuller C., Lau C., Boyett J. M., Wallace D., Gilbertson R. J., Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. The Lancet Oncology 2006 7 10 813 820 2-s2.0-33749044182 10.1016/S1470-2045(06)70867-1 (Pubitemid 44464063)
23. Kortmann R. D., Kühl J., Timmermann B., Mittler U., Urban C., Budach V., Richter E., Willich N., Flentje M., Berthold F., Slavc I., Wolff J., Meisner C., Wiestler O., Sörensen N., Warmuth-Metz M., Bamberg M., Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. International Journal of Radiation Oncology Biology Physics 2000 46 2 269 279 2-s2.0-0342614892 10.1016/S0360-3016(99)00369-7 (Pubitemid 30067775)
24. Miralbell R., Fitzgerald T. J., Laurie F., Kessel S., Glicksman A., Friedman H. S., Urie M., Kepner J. L., Zhou T., Chen Z., Barnes P., Kun L., Tarbell N. J., Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031. International Journal of Radiation Oncology Biology Physics 2006 64 5 1325 1330 2-s2.0-33645329333 10.1016/j.ijrobp.2005. 11.002
25. Sung K. W., Yoo K. H., Cho E. J., Koo H. H., Lim D. H., Shin H. J., Ahn S. D., Ra Y. S., Choi E. S., Ghim T. T., High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor. Pediatric Blood & Cancer 2007 48 4 408 415 2-s2.0-33847408394 10.1002/pbc.21064 (Pubitemid 46340106)